WO2009027983A1 - A buffer system for a long-lasting precast electrophoresis gel - Google Patents
A buffer system for a long-lasting precast electrophoresis gel Download PDFInfo
- Publication number
- WO2009027983A1 WO2009027983A1 PCT/IL2008/001174 IL2008001174W WO2009027983A1 WO 2009027983 A1 WO2009027983 A1 WO 2009027983A1 IL 2008001174 W IL2008001174 W IL 2008001174W WO 2009027983 A1 WO2009027983 A1 WO 2009027983A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- concentration
- gel
- tris
- gel according
- temperature
- Prior art date
Links
- 238000001962 electrophoresis Methods 0.000 title claims description 23
- 239000007853 buffer solution Substances 0.000 title description 10
- 230000005923 long-lasting effect Effects 0.000 title description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000000872 buffer Substances 0.000 claims abstract description 43
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000007983 Tris buffer Substances 0.000 claims abstract description 38
- 229920002401 polyacrylamide Polymers 0.000 claims abstract description 32
- 230000001747 exhibiting effect Effects 0.000 claims abstract description 15
- 238000001502 gel electrophoresis Methods 0.000 claims abstract description 13
- 150000003512 tertiary amines Chemical class 0.000 claims abstract description 11
- 150000003335 secondary amines Chemical class 0.000 claims abstract description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 49
- 102000004169 proteins and genes Human genes 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 239000004471 Glycine Substances 0.000 claims description 25
- 235000018102 proteins Nutrition 0.000 claims description 25
- 150000001412 amines Chemical class 0.000 claims description 22
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 21
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 21
- 229960001230 asparagine Drugs 0.000 claims description 21
- 235000009582 asparagine Nutrition 0.000 claims description 21
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 20
- 239000007995 HEPES buffer Substances 0.000 claims description 20
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 18
- -1 N,N'-disubstituted piperazine Chemical class 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 15
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 12
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 10
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 9
- 239000006035 Tryptophane Substances 0.000 claims description 9
- 125000002947 alkylene group Chemical group 0.000 claims description 9
- 229930182817 methionine Natural products 0.000 claims description 9
- 229960004799 tryptophan Drugs 0.000 claims description 9
- 238000004925 denaturation Methods 0.000 claims description 8
- 230000036425 denaturation Effects 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 claims description 4
- 239000007993 MOPS buffer Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000007992 BES buffer Substances 0.000 claims description 3
- 239000007996 HEPPS buffer Substances 0.000 claims description 3
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 claims description 3
- 239000007994 TES buffer Substances 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims description 3
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical group OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 claims description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 claims description 2
- GIZQLVPDAOBAFN-UHFFFAOYSA-N HEPPSO Chemical compound OCCN1CCN(CC(O)CS(O)(=O)=O)CC1 GIZQLVPDAOBAFN-UHFFFAOYSA-N 0.000 claims description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 2
- 238000005266 casting Methods 0.000 claims description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 229910006069 SO3H Inorganic materials 0.000 claims 2
- 102000015636 Oligopeptides Human genes 0.000 claims 1
- 108010038807 Oligopeptides Proteins 0.000 claims 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 142
- 238000003860 storage Methods 0.000 description 14
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000012146 running buffer Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920006063 Lamide® Polymers 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 0 *N1CCN(*O)CC1 Chemical compound *N1CCN(*O)CC1 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- UETQVDZZPKAQIC-UHFFFAOYSA-N chlorane Chemical compound Cl.Cl.Cl.Cl UETQVDZZPKAQIC-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003297 denaturating effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 150000004885 piperazines Chemical group 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/24—Homopolymers or copolymers of amides or imides
- C08L33/26—Homopolymers or copolymers of acrylamide or methacrylamide
Definitions
- the present invention relates to the field of gel electrophoresis. Specifically, the present invention relates to precast polyacrylamide gels having a long- lasting shelf life.
- Gel electrophoresis is a standard method in molecular biology to separate and identify biological molecules such as proteins, nucleic acids and oligos.
- Gels made of polyacrylamide (PAA) are commonly employed for electrophoresis due to convenient physical properties, including optical transparence, electrical neutrality and the ability to choose the desirable pore sizes.
- the SDS-polyacrylamide gel electrophoresis method is a powerful tool, which resolves proteins according to their molecular weights.
- the protein sample has to be initially denatured with SDS, an anionic detergent.
- SDS anions bind to the proteins, which consequently unfold and become uniformly coated with a negative charge, rendering the proteins similar in shape and charge-to-mass ratio.
- SDS will not only unfold proteins, but it will also separate those with several subunits into individual polypeptide chains.
- the mixture of the denatured proteins is subsequently loaded into a well that has been cast in the top of a polyacrylamide gel.
- the negatively charged polypeptides migrate through the gel towards the positive electrode at the bottom of the gel through a tangled network of polyacrylamide.
- Polypeptides which are smaller in size migrate more easily and faster through the network pores compared with the larger polypeptides.
- the distance traversed by the polypeptides in the gel relates only to their molecular weight as they all have a similar charge-to mass ratio.
- the current practice is to prepare and run the gels using basic buffers under basic conditions, with a typical pH around 8.8.
- the Laemmli buffer system which uses Tris(hydroxymethyl)aminomethane and hydrochloric acid (Tris- HCl) is a typical choice for the preparation of denaturing polyacrylamide gels.
- the Laemmli gels are composed of two different gels (stacking and separating gels), each cast at a different pH.
- the gel electrode buffer (running buffer) is at a third, different pH.
- the separating gel is buffered with Tris by adjusting it to pH 8.8 with HCl.
- the stacking gel and the sample buffer are also buffered with Tris but adjusted to pH 6.8 with HCl.
- the running buffer is also buffered by Tris but its pH is adjusted to be slightly below the separating gel using glycine only.
- US Pat. No. 6,783,651 discloses a buffer system for a long-lasting precast electrophoresis gel wherein separation occurs at neutral pH.
- the gel buffer solution in the buffer system contains a Bis-Tris titrated with hydrochloric acid to pH 7, while the running buffer solution contains MOPS or MES.
- Said electrophoresis gel system is described to have an increased useful shelf-life of up to twelve months, but the buffer system requires special molecule markers.
- the speed of electrophoretic migration is lower in the system when using prior art electrophoresis buffer solutions, for example a commonly available Laemmli's electrophoresis buffer solution containing glycine.
- US Pat. No. 6,733,647 describes a process for manufacturing gels with an extended shelf-life involving a gel buffer system comprising Tris at a concentration in the range of 0.15 to 0.25 M, titrated with HCl to a pH between 6.5-7.5.
- a gel buffer system comprising Tris at a concentration in the range of 0.15 to 0.25 M, titrated with HCl to a pH between 6.5-7.5.
- the system using running buffer containing glycine reduces the quality of the protein separation.
- US 6,726,821 alleviates some of the problems by combining glycine with an ampholyte and with Tris.
- the pH of the gel increases to about 7.1 during storage at 4°C, causing a notable hydrolysis in the aery lamide.
- the invention provides a precast polyacrylamide gel for use in gel electrophoresis, comprising i) an aqueous solution of tris(hydroxymethyl) aminomethane (Tris) at a concentration of 0.05 to 0.15 M; ii) a tertiary or secondary amine at a concentration of from 0.001 to 0.2 M comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of
- Tris tris(hydroxymethyl) aminomethane
- a precast gel according to the invention comprises preferably an aqueous solution of Tris at a concentration of 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of
- DSP N,N'-disubstituted piperazine
- R 1 and R2 are independently selected from C1-C4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.08 M or 0.2 to 0.4 M; and hydrochloric acid to adjust the pH to between 5.5 and 7.0 at the temperature of 25°C.
- the precast gel comprises an aqueous solution of Tris at a concentration of 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 8.0; of formula (I)
- a preferred precast gel of the invention comprises a N,N'- disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 7.6, of formula (I)
- Ri and R2 are independently selected from C2-C3 alkylene groups optionally substituted with a hydroxyl group; one or more ampholytes selected from the group consisting of glycine, serine, asparagine, tryptophane, methionine, and phenylalanine at a total concentration of from 0.2 to 0.4 M; hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 25°C; and poly aery lamide at a concentration of from about 4 w/v % to about 20 w/v %.
- the gel comprises asparagine and glycine at a total concentration of from 0.2 to 0.35 M.
- the invention provides a precast polyacrylamide gel for use in gel electrophoresis, comprising asparagine and serine at a total concentration of from 0.2 to 0.35 M.
- said DSP is HEPES.
- a gel according to the invention may comprise polyacrylamide at a concentration of from about 4 w/v % to about 20 w/v %.
- a gel according to the invention comprises Tris at a concentration of 0.06 to 0.1 M, HEPES at a concentration of from 0.001 to 0.1 M, one or more ampholytes at a total concentration of from 0.2 to 0.35 M selected from asparagine, serine, glycine, tryptophane, methionine, and phenylalanine, and hydrochloric acid to pH of from 6.2 to 6.8.
- a gel according to the invention may be used in gel electrophoresis under denaturation conditions, for example in an SDS-PAGE system.
- the gel of the invention may be used in gel electrophoresis under non-denaturating conditions.
- a gel according to the invention may further comprise at least one component selected from surfactants, solvents, electrolytes, denaturation agents, and dyes.
- the precast gel according to the invention comprises an aqueous solution of Tris at a concentration of 0.06 to 0.10 M; HEPES at a concentration of from 0.003 to 0.05 M; one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.2 to 0.35 M; polyacrylamide at a concentration of from about 4 w/v % to about 20 w/v %; optionally one or more components selected from surfactants, solvents, electrolytes, denaturation agents, preserving agents, and dyes; and hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 25 0 C.
- the invention thus, provides a precast polyacrylamide gel for use in gel electrophoresis, while combining some known components and obtaining surprisingly good performance.
- the improved gels comprise sulfonated amines exhibiting pKa of 6.6 to 8.0 at 25°C, ampholytes having pi of from 5.4 to 6.4, and tris-HCl providing the pH of 5.5-7.5; the tertiary or secondary amine having preferably a concentration of from 0.001 to 0.2 M, the ampholytes having a concentration in the range of 0.0 to 0.4 M.
- the invention provides electrophoretic gels with very high stability on storage, without compromising good separation of biomolecules when used in an electrophoretic system.
- a precast gel according to the invention has a shelf life of preferably more than three months, and most preferably more than 9 months. The gels are preferably stored at 4°C.
- the invention is directed to a method of preparing a stable, high performance gel for electrophoresis of biomolecules, comprising i) providing an aqueous solution comprising from 4 to 20 w/v % acrylamide (AA) and bis-acrylamide; Tris at 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) of formula (I)
- R 1 and R2 are independently selected from C 1 -C 4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; optionally one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.4 M; and hydrochloric acid to pH between 5.5 and 7.5 at the temperature of 25°C; ii) adding into the mixture obtained in step i) an aqueous solution of ammonium persulfate while mixing, and adding TEMED while mixing; iii) carefully homogenizing the mixture obtained in step ii) without trapping air bubbles; iv) casting the mixture obtained in step iii) into a slab-shape of desired dimensions; and v) sealing the slab-shaped gel in a polymeric wrap.
- R 1 and R2 are independently selected from C 1 -C 4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; optionally one or more ampholy
- a preferred method according to the invention comprises i) providing an aqueous solution comprising AA, Tris at a concentration of 0.05 to 0.15 M, HEPES at a concentration of from 0.001 to 0.1 M, at least one ampholyte selected from glycine, serine, asparagine, tryptophane, methionine, and phenylalanine at a concentration of from 0.2 to 0.35 M, and hydrochloric acid to a pH between 6.0 and 7.0; and polymerizing said AA, thereby obtaining a slab gel.
- the invention aims at simplifying the laboratory operations associated with analyzing and separating biomolecules by means of electrophoresis, by providing gels with increased storage stability of precast gels without compromising good separation.
- the gels may be employed in known electrophoresis systems.
- a precast polyacrylamide (PAA) gel combining certain sulfonated amines with certain amino acids, further comprising Tris- HCl and slightly acidic pH, exhibits superior storage stability without compromising electrophoresis performance.
- PAA polyacrylamide
- Particularly useful is an aqueous composition exhibiting a pH around 6.5, comprising a sulfonated tertiary or secondary amine at a concentration of from about 0.01 M to about 0.1 M, one or two ampholytes at a concentration of around 0.3 M having isoelectric point (pi) of around 6, and Tris at a concentration of around 0.1 M. It has been found that biomolecules are well separated on the gel, and that the good performance of the gel is preserved even when the gel is stored for prolonged periods of time, for example for one year.
- the performance of a precast gel depends on its composition at the time of its preparation, and further on the storage time. Involved are interactions between the initial gel components, the decomposition reactions in the gel during its storage, the interactions between the components and the analyzed biomolecules, etc.
- the separation of the biomolecule during an electrophoresis run is further affected by the electrophoresis conditions, such as the run time, the time courses of temperature and electric current, etc.
- the gel electrophoresis has, for many years, been one of the most frequently used methods in biochemistry and biotechnology, any improvement is enormous important.
- Tris should have a concentration of between 0.05 M and 0.15, said tertiary or secondary amine should have a concentration of from 0.001 M to 0.2 M and its pKa at 25 0 C should be from 6.6 to 8.0, said one or more ampholytes at a total concentration of from 0.01 M to 0.4 M, and hydrochloric acid should adjust the pH to between 5.5 and 7.5 at the temperature of 25 0 C.
- said ampholytes include amino acids having pi of from 5.4 to 6.4.
- a precast gel according to the invention preferably comprises an aqueous solution of Tris at a concentration of from 0.05 M to 0.15 M, for example from 0.06 M to 0.10 M, for example 0.07 M.
- Said precast gel preferably comprises a sulfonic group and a tertiary or secondary amine at a concentration of from 0.001 M to 0.2 M, more preferably from 0.001 M to 0.1 M, still more preferably from 0.003 M to 0.05 M, for example 0.02 M.
- secondary amines may include TES
- examples of tertiary amines may include BES.
- Preferred amines are tertiary amines. More preferred are amines having in the molecule two tertiary amino groups.
- the pKa of said amine at the temperature of 25 0 C has preferably a value of from 6.6 to 8.0, examples of such amines including HEPPS; more preferably said value is from 6.6 to 7.6, examples of such amines including MOPS.
- amines comprising an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25 0 C having a value of from 6.6 to 8.0, the examples including HEEPSO or HEPES; still more preferable are amines comprising a DSP comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 7.6, the examples including HEPES.
- DSP N,N'-disubstituted piperazine
- a precast gel according to the invention preferably comprises one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 M to 0.4 M, more preferably at a concentration of from 0.01 M to 0.08 M or from 0.2 M to 0.4 M, still more preferably form the range of 0.2 to 0.4 M, for example from 0.2 to 0.4 M or from 0.2 to 0.35 M.
- ampholyte include one or two ampholytes selected from glycine, serine, asparagine, tryptophane, methionine, and phenylalanine.
- Hydrochloric acid is added to the gel composition to adjust the pH to between 5.5 and 7.5 at the temperature of 25°C, preferably between 5.5 and 7.0, still more preferably from about 6 to about 7, for example from 6.1 to 6.9 or from 6.2 to 6.8.
- an electrophoretic system comprising the gel which maintains its initial high quality identification and separation of biomolecules even after one year of storage or more.
- Said system comprises the stable medium of the invention in which said biomolecules to be identified or separated move in the electric field, a commercial or other electrophoretic device providing said field, and necessary buffers in accordance with the required task, easily obtained or prepared by a person skilled in art (see, for example, Bollag et. al.: Protein Methods).
- the pH of said medium is maintained at a suitable value, for example 6.3, during the storage at 4 0 C, and prevents acrylamide hydrolysis in the gel.
- the ampholytes may be selected from amino acids, for example combinations of glycine, serine, asparagine, and phenylalanine.
- the instant system separates biomolecules of interest, while the initial good performance of the gel is preserved even when the gel is stored for prolonged periods, for example for one year.
- a preferred amine to be present in the gel is DSP, more preferably HEPES.
- the separating medium in a system according to the invention maintains the pH of the gel at a suitable value, for example 6.3, during the storage, and prevents acrylamide hydrolysis in the gel.
- composition for use in a precast polyacrylamide (PAA) gel according to the invention comprises a PAA or arylamide (AA) in the range of
- a gel for separating biomolecules according to the invention is a PAA gel comprising 12% AA, about 0.1 M Tris, about 0.1 M asparagine, about 0.2 M glycine, about 20 mM HEPES, and HCl to pH 6.3 at 25°C, which gel is used for separating polypeptides in the molecular range of
- the invention is thus directed to the method of separating biomolecules, comprising employing a PAA gel which preserves its superior separating features during prolonged storage, which gel contains beside Tris and a DSP also ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4, while the pH of the mixture is adjusted with HCl to a value between 6 and 7, for example to 6.1-6.8 or 6.2-6.6 or 6.3-6.5.
- the invention aims at providing a precast gel comprising PAA at a concentration of from about 4 w/v % to about 20 w/v %, for use in slab electrophoresis, the gel being sealed and stored for up to 12 months or more, and then used without a loss in the initial resolution power.
- a preferred gel according to the invention may be stored for more than one year, for example up to 13 months, or up to 14 months, or up to 15 months.
- said gel is used for electrophoresis under denaturation conditions.
- said denaturation conditions comprise the use of SDS in SDS- PAGE.
- said gel is used in gel electrophoresis under nondenaturation conditions.
- the gel is stored at a temperature lower than ambient, for example at about 4 0 C.
- the invention provides a method of preparing a stable, high performance gel for electrophoresis, comprising admixing, to an AA-containing mixture, ampholytes having pi of from 5.4 to 6.4, and a piperazine derivative substituted on both nitrogen atoms with alkylenes optionally branched and optionally further hydroxylated.
- ampholyte when using the term ampholyte in the instant specification, related to is a compound having in its molecule both basic and acidic groups, but excluding secondary or tertiary amines comprising in their molecules sulphonic groups.
- the gels were cast in mini gel cassettes (gel size 8 cm x 6 cm x 1 mm).
- the solutions used in polymerization were prepared by mixing stock solutions of acrylamide/Bis, Tris-HCl, Glycine, Asparagine, and HEPES, and by adding water to dilute to the appropriate concentration.
- the pH of the composition before polymerizing was adjusted to the required value by addition of HCl.
- Examples 1 and 2 relate to gels used immediately after their preparation
- Examples 3 and 4 relate to gels used after one-year storage at 4°C.
- a polyacrylamide gel was cast with an acrylamide concentration of
- a polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel.
- the concentration of Tris, Asparagine and HEPES in the gel was 0.07 M, 0.25 M and 0.02M respectively, the pH being adjusted to 6.3 using HCl.
- Samples of prestained molecular weight marker which was a commercially available marker containing samples denatured by the addition of DTT were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V.
- the proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15 kDa and 10 kDa.
- the markers were distributed along the gel such that the protein of 170 kDa was about 12% of the way down the gel and the protein of 10 kDa was about 85% of the way down the gel.
- a polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel.
- the concentration of Tris and Asparagine in the gel was 0.07 M and 0.25 M respectively, the pH being adjusted to 6.3 using HCl.
- the polyacrylamide gel obtained was stored for twelve months at 4°C. Samples of commercially available prestained molecular weight markers, denatured by the addition of DTT, were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V.
- the proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa.
- the markers were distributed along the gel such that the protein of 170 kDa was about 50% of the way down the gel and the protein of 40 kDa was about 95% of the way down the gel.
- pH of the gel increased from 6.3 to about 6.9, a notable hydrolysis was observed.
- a polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel.
- the concentration of Tris, Glycine, Asparagine and HEPES in the gel was 0.07 M, 0.2 M, 0.1 M and 0.02 M respectively, the pH being adjusted to 6.3 using HCl.
- the polyacrylamide gel obtained was stored at 4 0 C for twelve months.
- Samples of prestained molecular weight marker which was a commercially available marker containing samples denatured by the addition of DTT were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%).
- the gel was electrophoresed for 40 minutes at a voltage of 150V.
- the proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15 kDa and 10 kDa.
- the markers were distributed along the gel such that the protein of 170 kDa was about 13% of the way down the gel and the protein of 10 kDa was about 87% of the way down the gel.
- the added HEPES helped to keep the pH of the gel at about pH 6.2 under the storage at 4 0 C.
- the gels were remarkably retarded in the rate of hydrolysis compared with the gels without HEPES.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Provided is a precast polyacrylamide gel for use in gel electrophoresis, having a shelf-life of at least 12 months. The gel comprises a sulfonated tertiary or secondary amine having a pKa of 6.6-8.0, ampholytes exhibiting pI between 5.4 to 6.4, Tris, and hydrochloric acid to adjust the pH to between 5.5 and 7.5.
Description
A BUFFER SYSTEM FOR A LONG-LASTING PRECAST ELECTROPHORESIS GEL
Field of the Invention The present invention relates to the field of gel electrophoresis. Specifically, the present invention relates to precast polyacrylamide gels having a long- lasting shelf life.
Background of the Invention Gel electrophoresis is a standard method in molecular biology to separate and identify biological molecules such as proteins, nucleic acids and oligos. Gels made of polyacrylamide (PAA) are commonly employed for electrophoresis due to convenient physical properties, including optical transparence, electrical neutrality and the ability to choose the desirable pore sizes.
Particularly, the SDS-polyacrylamide gel electrophoresis method is a powerful tool, which resolves proteins according to their molecular weights. To counter the proteins' variations in shape, charge and size, the protein sample has to be initially denatured with SDS, an anionic detergent. The SDS anions bind to the proteins, which consequently unfold and become uniformly coated with a negative charge, rendering the proteins similar in shape and charge-to-mass ratio. Moreover, SDS will not only unfold proteins, but it will also separate those with several subunits into individual polypeptide chains. The mixture of the denatured proteins is subsequently loaded into a well that has been cast in the top of a polyacrylamide gel. Under an electric field, the negatively charged polypeptides migrate through the gel towards the positive electrode at the bottom of the gel through a tangled network of polyacrylamide. Polypeptides which are smaller in size migrate more easily and faster through the network pores compared with the larger polypeptides. The distance traversed by the polypeptides in the gel
relates only to their molecular weight as they all have a similar charge-to mass ratio.
The current practice is to prepare and run the gels using basic buffers under basic conditions, with a typical pH around 8.8. The Laemmli buffer system which uses Tris(hydroxymethyl)aminomethane and hydrochloric acid (Tris- HCl) is a typical choice for the preparation of denaturing polyacrylamide gels. The Laemmli gels are composed of two different gels (stacking and separating gels), each cast at a different pH. In addition, the gel electrode buffer (running buffer) is at a third, different pH. The separating gel is buffered with Tris by adjusting it to pH 8.8 with HCl. The stacking gel and the sample buffer are also buffered with Tris but adjusted to pH 6.8 with HCl. The running buffer is also buffered by Tris but its pH is adjusted to be slightly below the separating gel using glycine only.
These employment of gel and buffer discontinuities in the Laemmli system is designed to improve the resolution of electrophoresis (especially protein electrophoresis). The role of the chloride and glycine ions in this system is to establish a so called Kohlrausch boundary in the stacking gel in which the proteins are stacked into a thin layer between the leading chloride ions and the trailing glycine molecules.
Unfortunately the high pH values used in the separating gel in the Laemmli buffering system promote disulfide bond formation between cysteine residues in the proteins. Moreover, the high pH lowers the stability of the gels on storing. Currently, a major impediment in the production and sale of pre-cast polyacrylamide electrophoresis gel is the rather short shelf life of about three months. It is believed that the degradation of the gel is a consequence of hydrolysis of the amide groups to form partially anionic carboxylic acid derivatives under basic conditions. This hydrolysis leads to loss of resolution of the separated molecules, reduced migration distance of the separated molecules, and reduced intensity of protein staining.
Until recently, it has been thought that the degradation of the gels under basic conditions was inevitable. Attempts of extending the shelf life of gels by lowering the pH to circum neutral have been complicated by the parallel need for an effective yet inexpensive buffering system, as well as by the limitations regarding the concentration and pH of the buffers; lowering the gel pH to 7 or less may affect the ambit of molecular weights of the analyzed species, whereas Tris concentrations outside the range 0.05 - 0.2 M affect the electrophoresis pattern or the run time.
US Pat. No. 6,783,651 discloses a buffer system for a long-lasting precast electrophoresis gel wherein separation occurs at neutral pH. The gel buffer solution in the buffer system contains a Bis-Tris titrated with hydrochloric acid to pH 7, while the running buffer solution contains MOPS or MES. Said electrophoresis gel system is described to have an increased useful shelf-life of up to twelve months, but the buffer system requires special molecule markers. Moreover, the speed of electrophoretic migration is lower in the system when using prior art electrophoresis buffer solutions, for example a commonly available Laemmli's electrophoresis buffer solution containing glycine.
US Pat. No. 6,733,647 describes a process for manufacturing gels with an extended shelf-life involving a gel buffer system comprising Tris at a concentration in the range of 0.15 to 0.25 M, titrated with HCl to a pH between 6.5-7.5. Although the poly aery lamide gel has somewhat higher shelf-life, the system using running buffer containing glycine reduces the quality of the protein separation. US 6,726,821 alleviates some of the problems by combining glycine with an ampholyte and with Tris. However, the pH of the gel increases to about 7.1 during storage at 4°C, causing a notable hydrolysis in the aery lamide.
In view of the above problems, and further in view of the supreme importance of the electrophoresis techniques for progress in molecular
- A -
biology, there is continuing need for novel approaches. It is therefore an object of the invention to provide a precast polyacrylamide gel with a long shelf-life without compromising performance.
Other objects and advantages of present invention will appear as description proceeds.
Summary of the Invention
The invention provides a precast polyacrylamide gel for use in gel electrophoresis, comprising i) an aqueous solution of tris(hydroxymethyl) aminomethane (Tris) at a concentration of 0.05 to 0.15 M; ii) a tertiary or secondary amine at a concentration of from 0.001 to 0.2 M comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of
25°C having a value of from 6.6 to 8.0; iii) optionally one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.4 M; and iv) hydrochloric acid to adjust the pH to between
5.5 and 7.5 at the temperature of 25°C. A precast gel according to the invention comprises preferably an aqueous solution of Tris at a concentration of 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of
25°C having a value of from 6.6 to 8.0; of formula (I)
at a concentration of from 0.001 to 0.1 M, wherein R1 and R2 are independently selected from C1-C4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.08 M or 0.2 to 0.4 M; and hydrochloric acid to adjust the pH to between 5.5 and 7.0 at the temperature of 25°C. In a preferred embodiment of the
invention, the precast gel comprises an aqueous solution of Tris at a concentration of 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 8.0; of formula (I)
at a concentration of from 0.001 to 0.1 M, wherein R1 and R2 are independently selected from C2-C3 alkylene groups optionally substituted with a hydroxyl group; one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.2 to 0.4 M; and hydrochloric acid to adjust the pH to between 6.0 and 7.0 at the temperature of 250C. A preferred precast gel of the invention comprises a N,N'- disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 7.6, of formula (I)
at a concentration of from 0.01 to 0.1 M, wherein Ri and R2 are independently selected from C2-C3 alkylene groups optionally substituted with a hydroxyl group; one or more ampholytes selected from the group consisting of glycine, serine, asparagine, tryptophane, methionine, and phenylalanine at a total concentration of from 0.2 to 0.4 M; hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 25°C; and poly aery lamide at a concentration of from about 4 w/v % to about 20 w/v %. In a preferred embodiment of the invention, the gel comprises asparagine and glycine at a total concentration of from 0.2 to 0.35 M. In other preferred
embodiment, the invention provides a precast polyacrylamide gel for use in gel electrophoresis, comprising asparagine and serine at a total concentration of from 0.2 to 0.35 M. In an important aspect of the invention, said DSP is HEPES. A gel according to the invention may comprise polyacrylamide at a concentration of from about 4 w/v % to about 20 w/v %. In a preferred embodiment, a gel according to the invention comprises Tris at a concentration of 0.06 to 0.1 M, HEPES at a concentration of from 0.001 to 0.1 M, one or more ampholytes at a total concentration of from 0.2 to 0.35 M selected from asparagine, serine, glycine, tryptophane, methionine, and phenylalanine, and hydrochloric acid to pH of from 6.2 to 6.8. A gel according to the invention may be used in gel electrophoresis under denaturation conditions, for example in an SDS-PAGE system. The gel of the invention may be used in gel electrophoresis under non-denaturating conditions. A gel according to the invention may further comprise at least one component selected from surfactants, solvents, electrolytes, denaturation agents, and dyes. In a preferred component combination, the precast gel according to the invention comprises an aqueous solution of Tris at a concentration of 0.06 to 0.10 M; HEPES at a concentration of from 0.003 to 0.05 M; one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.2 to 0.35 M; polyacrylamide at a concentration of from about 4 w/v % to about 20 w/v %; optionally one or more components selected from surfactants, solvents, electrolytes, denaturation agents, preserving agents, and dyes; and hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 250C.
The invention, thus, provides a precast polyacrylamide gel for use in gel electrophoresis, while combining some known components and obtaining surprisingly good performance. Essentially, the improved gels comprise sulfonated amines exhibiting pKa of 6.6 to 8.0 at 25°C, ampholytes having pi of from 5.4 to 6.4, and tris-HCl providing the pH of 5.5-7.5; the tertiary or secondary amine having preferably a concentration of from 0.001 to 0.2 M, the ampholytes having a concentration in the range of 0.0 to 0.4 M. The
invention provides electrophoretic gels with very high stability on storage, without compromising good separation of biomolecules when used in an electrophoretic system. Examples of said amine include BES, MOPS, TES, HEPES, HEPPS (abbreviated also as EPPS), and HEPPSO; examples of said ampholyte include glycine, serine, asparagine, tryptophane, methionine, and phenylalanine. A precast gel according to the invention has a shelf life of preferably more than three months, and most preferably more than 9 months. The gels are preferably stored at 4°C.
The invention is directed to a method of preparing a stable, high performance gel for electrophoresis of biomolecules, comprising i) providing an aqueous solution comprising from 4 to 20 w/v % acrylamide (AA) and bis-acrylamide; Tris at 0.05 to 0.15 M; an N,N'-disubstituted piperazine (DSP) of formula (I)
at a concentration of from 0.001 to 0.2 M, wherein R1 and R2 are independently selected from C1-C4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; optionally one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.4 M; and hydrochloric acid to pH between 5.5 and 7.5 at the temperature of 25°C; ii) adding into the mixture obtained in step i) an aqueous solution of ammonium persulfate while mixing, and adding TEMED while mixing; iii) carefully homogenizing the mixture obtained in step ii) without trapping air bubbles; iv) casting the mixture obtained in step iii) into a slab-shape of desired dimensions; and v) sealing the slab-shaped gel in a polymeric wrap. A preferred method according to the invention comprises i) providing an aqueous solution comprising AA, Tris at a concentration of 0.05 to 0.15 M, HEPES at a concentration of from 0.001 to 0.1 M, at least one ampholyte selected from glycine, serine, asparagine, tryptophane,
methionine, and phenylalanine at a concentration of from 0.2 to 0.35 M, and hydrochloric acid to a pH between 6.0 and 7.0; and polymerizing said AA, thereby obtaining a slab gel.
The invention aims at simplifying the laboratory operations associated with analyzing and separating biomolecules by means of electrophoresis, by providing gels with increased storage stability of precast gels without compromising good separation. The gels may be employed in known electrophoresis systems.
Detailed Description of the Invention
It has now been found that a precast polyacrylamide (PAA) gel combining certain sulfonated amines with certain amino acids, further comprising Tris- HCl and slightly acidic pH, exhibits superior storage stability without compromising electrophoresis performance. Particularly useful is an aqueous composition exhibiting a pH around 6.5, comprising a sulfonated tertiary or secondary amine at a concentration of from about 0.01 M to about 0.1 M, one or two ampholytes at a concentration of around 0.3 M having isoelectric point (pi) of around 6, and Tris at a concentration of around 0.1 M. It has been found that biomolecules are well separated on the gel, and that the good performance of the gel is preserved even when the gel is stored for prolonged periods of time, for example for one year.
The performance of a precast gel depends on its composition at the time of its preparation, and further on the storage time. Involved are interactions between the initial gel components, the decomposition reactions in the gel during its storage, the interactions between the components and the analyzed biomolecules, etc. The separation of the biomolecule during an electrophoresis run is further affected by the electrophoresis conditions, such as the run time, the time courses of temperature and electric current, etc. In view of so many compounds being possibly combined in the gel, and so many
parameters possibly affecting the performance, it is nearly impossible to predict an effect of even a minor change in the system. Since the gel electrophoresis has, for many years, been one of the most frequently used methods in biochemistry and biotechnology, any improvement is immensely important.
It has now been found that superior storage behavior is exhibited by gels of the invention that comprise a sulfonated tertiary amine, such as an N5N1- disubstituted piperazine (DSP), whereas the presence of ampholytes having a pi between 5.4 and 6.4 is advantageous. Important is, in the gel of the invention, the presence of Tris and its titration by an inorganic acid, particularly by hydrochloric acid (HCl). The neutralization of Tris by a strong acid, rather than by acetic acid or even by an ampholyte, is believed to contribute to the good performance of said gel. In a preferred aqueous composition to be comprised in the gel of the invention, Tris should have a concentration of between 0.05 M and 0.15, said tertiary or secondary amine should have a concentration of from 0.001 M to 0.2 M and its pKa at 250C should be from 6.6 to 8.0, said one or more ampholytes at a total concentration of from 0.01 M to 0.4 M, and hydrochloric acid should adjust the pH to between 5.5 and 7.5 at the temperature of 250C. Examples of said ampholytes include amino acids having pi of from 5.4 to 6.4.
A precast gel according to the invention preferably comprises an aqueous solution of Tris at a concentration of from 0.05 M to 0.15 M, for example from 0.06 M to 0.10 M, for example 0.07 M. Said precast gel preferably comprises a sulfonic group and a tertiary or secondary amine at a concentration of from 0.001 M to 0.2 M, more preferably from 0.001 M to 0.1 M, still more preferably from 0.003 M to 0.05 M, for example 0.02 M. Examples of secondary amines may include TES, examples of tertiary amines may include BES. Preferred amines are tertiary amines. More preferred are amines having in the molecule two tertiary amino groups. The pKa of said amine at the temperature of 250C has preferably a value of from 6.6 to 8.0, examples of
such amines including HEPPS; more preferably said value is from 6.6 to 7.6, examples of such amines including MOPS. Still more preferable are amines comprising an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 250C having a value of from 6.6 to 8.0, the examples including HEEPSO or HEPES; still more preferable are amines comprising a DSP comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 7.6, the examples including HEPES. A precast gel according to the invention preferably comprises one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 M to 0.4 M, more preferably at a concentration of from 0.01 M to 0.08 M or from 0.2 M to 0.4 M, still more preferably form the range of 0.2 to 0.4 M, for example from 0.2 to 0.4 M or from 0.2 to 0.35 M. Examples of said ampholyte include one or two ampholytes selected from glycine, serine, asparagine, tryptophane, methionine, and phenylalanine. Hydrochloric acid is added to the gel composition to adjust the pH to between 5.5 and 7.5 at the temperature of 25°C, preferably between 5.5 and 7.0, still more preferably from about 6 to about 7, for example from 6.1 to 6.9 or from 6.2 to 6.8.
Thus, an electrophoretic system is now enabled, comprising the gel which maintains its initial high quality identification and separation of biomolecules even after one year of storage or more. Said system comprises the stable medium of the invention in which said biomolecules to be identified or separated move in the electric field, a commercial or other electrophoretic device providing said field, and necessary buffers in accordance with the required task, easily obtained or prepared by a person skilled in art (see, for example, Bollag et. al.: Protein Methods). In said system, the pH of said medium is maintained at a suitable value, for example 6.3, during the storage at 40C, and prevents acrylamide hydrolysis in the gel. The ampholytes may be selected from amino acids, for example combinations of glycine, serine, asparagine, and phenylalanine.
The instant system separates biomolecules of interest, while the initial good performance of the gel is preserved even when the gel is stored for prolonged periods, for example for one year. A preferred amine to be present in the gel is DSP, more preferably HEPES. The separating medium in a system according to the invention maintains the pH of the gel at a suitable value, for example 6.3, during the storage, and prevents acrylamide hydrolysis in the gel.
An example of the composition for use in a precast polyacrylamide (PAA) gel according to the invention comprises a PAA or arylamide (AA) in the range of
4-12 %, about 70 mM Tris, about 200 mM asparagine, and about 20 mM
HEPES. Another example of a gel for separating biomolecules according to the invention is a PAA gel comprising 12% AA, about 0.1 M Tris, about 0.1 M asparagine, about 0.2 M glycine, about 20 mM HEPES, and HCl to pH 6.3 at 25°C, which gel is used for separating polypeptides in the molecular range of
10-170 kDa.
The invention is thus directed to the method of separating biomolecules, comprising employing a PAA gel which preserves its superior separating features during prolonged storage, which gel contains beside Tris and a DSP also ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4, while the pH of the mixture is adjusted with HCl to a value between 6 and 7, for example to 6.1-6.8 or 6.2-6.6 or 6.3-6.5.
The invention aims at providing a precast gel comprising PAA at a concentration of from about 4 w/v % to about 20 w/v %, for use in slab electrophoresis, the gel being sealed and stored for up to 12 months or more, and then used without a loss in the initial resolution power. A preferred gel according to the invention may be stored for more than one year, for example up to 13 months, or up to 14 months, or up to 15 months. In one aspect of the invention, said gel is used for electrophoresis under denaturation conditions. Preferably said denaturation conditions comprise the use of SDS in SDS-
PAGE. In another aspect of the invention, said gel is used in gel electrophoresis under nondenaturation conditions. Preferably, the gel is stored at a temperature lower than ambient, for example at about 40C.
The invention provides a method of preparing a stable, high performance gel for electrophoresis, comprising admixing, to an AA-containing mixture, ampholytes having pi of from 5.4 to 6.4, and a piperazine derivative substituted on both nitrogen atoms with alkylenes optionally branched and optionally further hydroxylated.
When using the term ampholyte in the instant specification, related to is a compound having in its molecule both basic and acidic groups, but excluding secondary or tertiary amines comprising in their molecules sulphonic groups.
These and other aspects of the invention will become clear from the following examples, which are illustrative only and do not limit the invention.
Examples
The gels were cast in mini gel cassettes (gel size 8 cm x 6 cm x 1 mm). The solutions used in polymerization were prepared by mixing stock solutions of acrylamide/Bis, Tris-HCl, Glycine, Asparagine, and HEPES, and by adding water to dilute to the appropriate concentration. The pH of the composition before polymerizing was adjusted to the required value by addition of HCl.
Examples 1 and 2 relate to gels used immediately after their preparation, Examples 3 and 4 relate to gels used after one-year storage at 4°C.
Example 1
A polyacrylamide gel was cast with an acrylamide concentration of
4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel. The concentration of Tris and Asparagine in the gel composition was
0.07 M and 0.25 M respectively, the pH being adjusted to 6.3 using HCl.
Samples of prestained molecular weight marker which was a commercially available marker containing samples denatured by the addition of DTT were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V. The proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15 kDa and 10 kDa. The markers were distributed along the gel such that the protein of 170 kDa was about 16% of the way down the gel and the protein of 10 kDa was about 90% of the way down the gel.
Example 2
A polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel. The concentration of Tris, Asparagine and HEPES in the gel was 0.07 M, 0.25 M and 0.02M respectively, the pH being adjusted to 6.3 using HCl. Samples of prestained molecular weight marker which was a commercially available marker containing samples denatured by the addition of DTT were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V. The proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15 kDa and 10 kDa. The markers were distributed along the gel such that the protein of 170 kDa was about 12% of the way down the gel and the protein of 10 kDa was about 85% of the way down the gel.
Example 3
A polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel. The concentration of Tris and Asparagine in the gel was 0.07 M and 0.25 M respectively, the pH being adjusted to 6.3 using HCl. The polyacrylamide gel obtained was stored for twelve months at 4°C. Samples of commercially available prestained molecular weight markers, denatured by
the addition of DTT, were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V. The proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa. The markers were distributed along the gel such that the protein of 170 kDa was about 50% of the way down the gel and the protein of 40 kDa was about 95% of the way down the gel. During the gel storage at 40C, while pH of the gel increased from 6.3 to about 6.9, a notable hydrolysis was observed.
Example 4
A polyacrylamide gel was cast with an acrylamide concentration of 4%T/2.6%C in the stacking region and 12%T/2.6%C in the resolving region of the gel. The concentration of Tris, Glycine, Asparagine and HEPES in the gel was 0.07 M, 0.2 M, 0.1 M and 0.02 M respectively, the pH being adjusted to 6.3 using HCl. The polyacrylamide gel obtained was stored at 40C for twelve months. Samples of prestained molecular weight marker which was a commercially available marker containing samples denatured by the addition of DTT were separated on this gel using an electrode buffer of Tris (25 mM), Glycine (191 mM) and SDS (0.1%). The gel was electrophoresed for 40 minutes at a voltage of 150V. The proteins in the standard that remained on the gel were 170 kDa, 130 kDa, 100 kDa, 70 kDa, 55 kDa, 40 kDa, 35 kDa, 25 kDa, 15 kDa and 10 kDa. The markers were distributed along the gel such that the protein of 170 kDa was about 13% of the way down the gel and the protein of 10 kDa was about 87% of the way down the gel. The added HEPES helped to keep the pH of the gel at about pH 6.2 under the storage at 40C. The gels were remarkably retarded in the rate of hydrolysis compared with the gels without HEPES. This made it possible to store the gels for over a year without no change or deterioration in the gel shape and performance.
While this invention has been described in terms of some specific examples, many modifications and variations are possible. It is therefore understood that within the scope of the appended claims, the invention may be realized otherwise than as specifically described.
Claims
1. A precast polyacrylamide gel for use in gel electrophoresis, comprising i) an aqueous solution of tris(hydroxymethyl)aminomethane (Tris) at a concentration of from 0.05 M to 0.15 M; ii) a tertiary or secondary amine at a concentration of from 0.001 M to
0.2 M comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 250C having a value of from 6.6 to 8.0; in) optionally one or more ampholytes exhibiting an isoelectric point
(pi) of from 5.4 to 6.4 at a total concentration of from 0.01 M to 0.4
M; and iv) hydrochloric acid to adjust the pH to between 5.5 and 7.5 at the temperature of 25°C.
2. A precast gel according to claim 1, comprising i) an aqueous solution of Tris at a concentration of 0.05 to 0.15 M; ii) an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 250C having a value of from 6.6 to 8.0, of formula (I)
OH— R1- N N -R2 — SO3H (D
at a concentration of from 0.001 M to 0.1 M, wherein
R1 and R2 are independently selected from CI-CA alkylene groups optionally substituted with a lower alkyl or hydroxyl group; iii) one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.08 or from 0.2 M to 0.4 M; and iv) hydrochloric acid to adjust the pH to between 5.5 and 7.0 at the temperature of 25°C.
3. A precast gel according to claim 1, comprising i) an aqueous solution of Tris at a concentration of from 0.05 M to 0.15 M; ϋ) an N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 8.0, of formula (I)
at a concentration of from 0.001 M to 0.1 M, wherein
Ri and R2 are independently selected from C2-C3 alkylene groups optionally substituted with a hydroxyl group; iii) one or more ampholytes exhibiting an isoelectric point (pi) of from
5.4 to 6.4 at a total concentration of from 0.2 M to 0.4 M; and iv) hydrochloric acid to adjust the pH to between 6.0 and 7.0 at the temperature of 250C.
4. A precast gel according to claim 1, comprising i) Tris at a concentration of 0.06 M to 0.10 M; ii) a N,N'-disubstituted piperazine (DSP) comprising in the molecule one sulfonic group, the pKa of said amine at the temperature of 25°C having a value of from 6.6 to 7.6, of formula (I)
at a concentration of from 0.01 M to 0.1 M, wherein Ri and R2 are independently selected from C2-C3 alkylene groups optionally substituted with a hydroxyl group; iii) one or more ampholytes selected from the group consisting of
glycine, serine, asparagine, tryptophane, methionine, and phenylalanine at a total concentration of from 0.2 M to 0.4 M; iv) hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 250C; and v) polyacrylamide at a concentration of from about 4 w/v % to about
20 w/v %.
5. A gel according to claim 4, comprising asparagine and glycine at a total concentration of from 0.2 M to 0.35 M.
6. A gel according to claim 4, comprising asparagine and serine at a total concentration of from 0.2 M to 0.35 M.
7. A gel according to claim 4, wherein said DSP is HEPES.
8. A gel according to claim 1, comprising polyacrylamide at a concentration of from about 4 w/v % to about 20 w/v %.
9. A gel according to claim 1, comprising Tris at a concentration of 0.06 to 0.1 M, HEPES at a concentration of from 0.001 to 0.1 M, one or more ampholytes at a total concentration of from 0.2 to 0.35 M selected from asparagine, serine, glycine, tryptophane, methionine, and phenylalanine, and hydrochloric acid to pH of from 6.2 to 6.8.
10. A gel according to claim 1 for use in gel electrophoresis under denaturation conditions.
11. A gel according to claim 10, wherein said electrophoresis is SDS-PAGE.
12. A gel according to claim 1 for use in gel electrophoresis under nondenaturation conditions.
13. A gel according to claim 1, further comprising at least one component selected from surfactants, solvents, electrolytes, denaturation agents, and dyes.
14. A precast gel according to claim 1, comprising i) an aqueous solution of tris(hydroxymethyl)aminomethane (Tris) at a concentration of 0.06 to 0.10 M; ii) HEPES at a concentration of from 0.003 to 0.05 M; Ui) one or more ampholytes exhibiting an isoelectric point (pi) of from
5.4 to 6.4 at a total concentration of from 0.2 to 0.35 M; iv) polyacrylamide at a concentration of from about 4 w/v % to about
20 w/v %; v) optionally one or more components selected from surfactants, solvents, electrolytes, denaturation agents, and dyes; and vi) hydrochloric acid to adjust the pH to between 6.2 and 6.8 at the temperature of 250C.
15. A precast gel according to any one of claims 1 to 14, having a shelf life of at least 12 months.
16. A method of preparing a stable, high performance gel for electrophoresis of biomolecules, comprising i) providing an aqueous solution comprising from 4 to 20 w/v % acrylamide (AA) and bis-acrylamide; from 0.05 to 0.15 M Tris; an N,N'-disubstituted piperazine (DSP) of formula (I)
OH— R1- N N — R2 — SO3H (D
at a concentration of from 0.001 to 0.2 M, wherein R1 and R2 are independently selected from C1-C4 alkylene groups optionally substituted with a lower alkyl or hydroxyl group; optionally one or more ampholytes exhibiting an isoelectric point (pi) of from 5.4 to 6.4 at a total concentration of from 0.01 to 0.4 M; and hydrochloric acid to pH between 5.5 and 7.5 at the temperature of 250C;
ϋ) adding into the mixture obtained in step i) an aqueous solution of ammonium persulfate while mixing, and adding TEMED while mixing; iii) carefully homogenizing the mixture obtained in step ii) without trapping air bubbles; iv) casting the mixture obtained in step iii) into a slab-shape of desired dimensions; and v) sealing the slab-shaped gel in a polymeric wrap.
17. A method according to claim 16, comprising i) providing an aqueous solution comprising AA, Tris at a concentration of 0.05 to 0.15 M, HEPES at a concentration of from 0.001 to 0.1 M, at least one ampholyte selected from glycine, serine, asparagine, tryptophane, methionine, and phenylalanine at a concentration of from 0.2 to 0.35 M, and hydrochloric acid to a pH between 6.0 and 7.0; and polymerizing said AA, thereby obtaining a slab gel.
18. A method according to claim 16, wherein said biomolecule is selected from oligopeptides, polypeptides, oligonucleotides, and polynucleotides.
19. A method according to claim 16, wherein said biomolecule is selected from proteins and nucleic acids.
20. A precast gel according to claim 1, wherein said amine is selected from BES, MOPS, TES, HEPES, HEPPS, and HEPPSO.
21. A precast gel according to claim 1, wherein said ampholytes is selected from the group consisting of glycine, serine, asparagine, tryptophane, methionine, and phenylalanine.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/675,099 US20100264031A1 (en) | 2007-08-30 | 2008-08-31 | buffer system for a long-lasting precast electrophoresis gel |
EP08789846A EP2183583B1 (en) | 2007-08-30 | 2008-08-31 | A buffer system for a long-lasting precast electrophoresis gel |
AT08789846T ATE511641T1 (en) | 2007-08-30 | 2008-08-31 | BUFFER SYSTEM FOR A LONG-LASTING FINISHED CAST ELECTROPHORE SAIL |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL185638A IL185638A0 (en) | 2007-08-30 | 2007-08-30 | A buffer system for a long-lasting precast electrophoresis gel |
IL185638 | 2007-08-30 | ||
IL189759 | 2008-02-25 | ||
IL189760A IL189760A0 (en) | 2008-02-25 | 2008-02-25 | A buffer system for a long-lasting precast electrophoresis gel |
IL18975908 | 2008-02-25 | ||
IL189760 | 2008-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009027983A1 true WO2009027983A1 (en) | 2009-03-05 |
Family
ID=40084215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2008/001174 WO2009027983A1 (en) | 2007-08-30 | 2008-08-31 | A buffer system for a long-lasting precast electrophoresis gel |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100264031A1 (en) |
EP (1) | EP2183583B1 (en) |
AT (1) | ATE511641T1 (en) |
WO (1) | WO2009027983A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011028535A2 (en) | 2009-08-24 | 2011-03-10 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
US9103779B2 (en) | 2010-04-27 | 2015-08-11 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
EP3399307A1 (en) * | 2009-08-24 | 2018-11-07 | Life Technologies Corporation | Electrophoresis gel cassette and comb |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945360B2 (en) * | 2009-01-27 | 2015-02-03 | Bio-Rad Laboratories, Inc. | High-performing electrophoresis gels with extended shelf lives |
JP2012029676A (en) * | 2010-07-07 | 2012-02-16 | Sony Corp | Cartridge for concentrating and collecting nucleic acid, method for concentrating and collecting nucleic acid and method for fabricating the cartridge |
US10983090B2 (en) | 2015-10-14 | 2021-04-20 | Life Technologies Corporation | Electrophoresis gel with extended shelf life and high performance |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0566784A1 (en) * | 1990-11-19 | 1993-10-27 | Hymo Corporation | Polyacrylamide gel for electrophoresis |
WO2001060841A1 (en) * | 2000-02-18 | 2001-08-23 | Gradipore Limited | Improved electrophoresis gels |
EP1167962A1 (en) * | 1999-12-02 | 2002-01-02 | Hymo Corporation | Polyacrylamide precast gels for electrophoresis, process for producing the same and electrophoresis method by using the gels |
US20050121325A1 (en) * | 2003-09-19 | 2005-06-09 | Timothy Updyke | Composite compositions for electrophoresis |
WO2007076452A1 (en) * | 2005-12-29 | 2007-07-05 | Invitrogen Corporation | Compositions and methods for improving resolution of biomolecules separated on polyacrylamide gels |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019232A (en) * | 1990-06-01 | 1991-05-28 | Minnesota Mining And Manufacturing Company | Medium for electrophoresis |
US6783651B1 (en) * | 1994-03-31 | 2004-08-31 | Invitrogen Corporation | System for pH-neutral stable electrophoresis gel |
US6379519B1 (en) * | 1999-09-01 | 2002-04-30 | Mirador Dna Design Inc. | Disposable thermoformed electrophoresis cassette |
IL166716A0 (en) * | 2005-02-07 | 2006-01-15 | Gene Bio Applic Ltd | Double chamber tank for electrophoresis |
EP1853696B1 (en) * | 2005-02-24 | 2019-04-17 | Life Technologies (Israel) Ltd. | Electro-blotting devices, systems, and kits, and methods for their use |
-
2008
- 2008-08-31 WO PCT/IL2008/001174 patent/WO2009027983A1/en active Application Filing
- 2008-08-31 US US12/675,099 patent/US20100264031A1/en not_active Abandoned
- 2008-08-31 EP EP08789846A patent/EP2183583B1/en not_active Not-in-force
- 2008-08-31 AT AT08789846T patent/ATE511641T1/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0566784A1 (en) * | 1990-11-19 | 1993-10-27 | Hymo Corporation | Polyacrylamide gel for electrophoresis |
EP1167962A1 (en) * | 1999-12-02 | 2002-01-02 | Hymo Corporation | Polyacrylamide precast gels for electrophoresis, process for producing the same and electrophoresis method by using the gels |
WO2001060841A1 (en) * | 2000-02-18 | 2001-08-23 | Gradipore Limited | Improved electrophoresis gels |
US20050121325A1 (en) * | 2003-09-19 | 2005-06-09 | Timothy Updyke | Composite compositions for electrophoresis |
WO2007076452A1 (en) * | 2005-12-29 | 2007-07-05 | Invitrogen Corporation | Compositions and methods for improving resolution of biomolecules separated on polyacrylamide gels |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102576003B (en) * | 2009-08-24 | 2015-11-25 | 生命技术公司 | For the system of fast hi-resolution gel electrophoresis |
WO2011028535A2 (en) | 2009-08-24 | 2011-03-10 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
WO2011028535A3 (en) * | 2009-08-24 | 2011-05-05 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
CN102576003A (en) * | 2009-08-24 | 2012-07-11 | 生命技术公司 | System for rapid high-resolution gel electrophoresis |
JP2013502599A (en) * | 2009-08-24 | 2013-01-24 | ライフ テクノロジーズ コーポレーション | A system for high-speed, high-resolution gel electrophoresis. |
US11105769B2 (en) | 2009-08-24 | 2021-08-31 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
US20110073478A1 (en) * | 2009-08-24 | 2011-03-31 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
US10613052B2 (en) | 2009-08-24 | 2020-04-07 | Life Technologies Corporation | Electrophoresis gel cassette and comb |
EP3296732A1 (en) * | 2009-08-24 | 2018-03-21 | Life Technologies Corporation | System for rapid high-resolution gel electrophoresis |
CN105445355A (en) * | 2009-08-24 | 2016-03-30 | 生命技术公司 | System for rapid high-resolution gel electrophoresis |
EP3399307A1 (en) * | 2009-08-24 | 2018-11-07 | Life Technologies Corporation | Electrophoresis gel cassette and comb |
US9267916B2 (en) | 2010-04-27 | 2016-02-23 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
AU2011245047B2 (en) * | 2010-04-27 | 2016-01-28 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
US9103779B2 (en) | 2010-04-27 | 2015-08-11 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
Also Published As
Publication number | Publication date |
---|---|
US20100264031A1 (en) | 2010-10-21 |
EP2183583A1 (en) | 2010-05-12 |
ATE511641T1 (en) | 2011-06-15 |
EP2183583B1 (en) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100368955B1 (en) | Separation electrophoretic gel, gel electrophoresis system and electrophoretic method using the same | |
US11105769B2 (en) | System for rapid high-resolution gel electrophoresis | |
EP2183583B1 (en) | A buffer system for a long-lasting precast electrophoresis gel | |
JP5827262B2 (en) | Hydrolysis resistant polyacrylamide gel | |
US20050167268A1 (en) | System for pH-neutral stable electrophoresis gel | |
JP5547751B2 (en) | High performance electrophoresis gel with extended shelf life | |
US20060118418A1 (en) | Electrophoresis gels and buffers and methods of performing electrophoresis | |
US20110308951A1 (en) | Long-lasting precast electrophoresis gel | |
JP3553604B2 (en) | A new buffer system for electrophoresis and its use | |
Busnel et al. | Evaluation of capillary isoelectric focusing in glycerol‐water media with a view to hydrophobic protein applications | |
US20100213060A1 (en) | Aqueous transfer buffer | |
US9267916B2 (en) | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life | |
JP5967751B2 (en) | Precast gel for electrophoresis, production method and use thereof | |
WO2000067009A1 (en) | Mixed buffers in gel electrophoresis systems | |
JP2018530758A (en) | Electrophoretic gel with extended shelf life and high performance | |
JP2001242139A (en) | Electrophoresis method for dna | |
WO2004020991A1 (en) | An electrophoresis gel having improved swelling properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08789846 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008789846 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12675099 Country of ref document: US |